MktsMarkets

Thermo Fisher Scientific Inc
NYSE: TMOKey statistics
TMO News
Stories mentioning TMO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 28 | Q4 '25Dec 31 | Q3 '25Sep 27 | Q2 '25Jun 28 | Q1 '25Mar 29 | Q4 '24Dec 31 | Q3 '24Sep 28 | Q2 '24Jun 29 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 11,005,000 | 12,215,000 | 11,122,000 | 10,855,000 | 10,364,000 | 11,395,000 | 10,598,000 | 10,541,000 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 336,000 | 357,000 | 346,000 | 352,000 | 342,000 | 374,000 | 346,000 | 339,000 |
| Sales General & Admin | 2,181,000 | 2,352,000 | 2,162,000 | 2,140,000 | 2,078,000 | 2,203,000 | 2,098,000 | 2,111,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 1,863,000 | 2,255,000 | 1,941,000 | 1,834,000 | 1,716,000 | 2,016,000 | 1,838,000 | 1,820,000 |
| Interest Income | 233,000 | 259,000 | 234,000 | 297,000 | 203,000 | 227,000 | 277,000 | 295,000 |
| Interest Expense | ||||||||
| Other Expense | (9,000) | 6,000 | (2,000) | (19,000) | 3,000 | 13,000 | (16,000) | 5,000 |
| Pretax Income | ||||||||
| Tax Provision | 70,000 | 153,000 | 207,000 | 92,000 | 95,000 | 149,000 | 99,000 | 128,000 |
| Net Income (Loss) | 1,651,000 | 1,964,000 | 1,616,000 | 1,617,000 | 1,507,000 | 1,630,000 | 1,548,000 | |
| Earnings Per Share (Basic) | 4.44 | 5.21 | 4.28 | 4.28 | 3.99 | 0.00 | 4.26 | 4.05 |
| Earnings Per Share (Diluted) | 4.43 | 5.20 | 4.27 | 4.28 | 3.98 | 0.00 | 4.25 | 4.04 |
| Weighted Average Shares Outstanding (Basic) | 372,000 | 377,000 | 378,000 | 378,000 | 378,000 | 382,000 | 382,000 | 382,000 |
| Weighted Average Shares Outstanding (Diluted) | 373,000 | 378,000 | 378,000 | 378,000 | 379,000 | 383,000 | 384,000 | 383,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TMO
Thermo Fisher Scientific Inc (NYSE: TMO) is a stock listed on the New York Stock Exchange under the ticker symbol TMO. It last traded at $691.33 (Nov 16, 2026, 4:00 PM ET), down 1.3% on the day. That gives Thermo Fisher Scientific a market capitalisation of $256.6B and a price-to-earnings ratio of 36.3.
Over the past 52 weeks TMO has traded between $435.27 and $727.56.
Revenue for the quarter ended Mar 28, 2026 was $11.0B; net income $1.7B. Revenue was up 6.2% from $10.4B in the quarter ended Mar 29, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 28, 2026 | $11.0B | $1.7B | 15.0% |
| Dec 31, 2025 | $12.2B | $2.0B | 16.1% |
| Sep 27, 2025 | $11.1B | $1.6B | 14.5% |
| Jun 28, 2025 | $10.9B | $1.6B | 14.9% |
From Thermo Fisher Scientific’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…